CRP and Behcet disease: Regarding the biochemical profile (Table 1), FINEXT‐BD participants showed higher values above the optimal concentration of atherogenic indexes (i.e., TC/HDL‐C > 3.5; TG/HDL‐C > 2) and C‐reactive protein (CRP), a proinflammatory biomarker considered cardiometabolically unhealthy per values > 3 mg/L.